Evidence map›Paper›PMID 29109762›Full record

ArticleOncology letters2017

Stability analysis on the radioactive iodine-labelled prostate cancer-specific recombinant oncolytic adenovirus.

Jiahe Zhou, Lin Hao, Zhenduo Shi, Songyi Ning, Houguang He, Yan Zhao, Yang Dong, Zhigang Li, Jiuxiang He, Guanghui Zang and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jiahe ZhouDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Lin HaoDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Zhenduo ShiDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Songyi NingJiangsu University School of Medicine, Zhenjiang, Jiangsu 212013, P.R. China.
Houguang HeDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Yan ZhaoKunshan Ruike Research and Development of Medicine Co., Ltd., Kunshan, Jiangsu 215300, P.R. China.
Yang DongDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Zhigang LiDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Jiuxiang HeChongqing Western Biomedical Technology Co., Chongqing 400010, P.R. China.
Guanghui ZangDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Conghui HanDepartment of Urinary Surgery, Xuzhou School of Clinical Medicine Affiliated to Xuzhou Medicine University, Xuzhou, Jiangsu 221009, P.R. China.
Xuzhou Medical College · CNJiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to construct the

Indexed as

125Icastrate-resistant prostate cancerhuman telomerase reverse transcriptaseprostate specific antigenreplication- selective oncolytic adenovirus

Identifiers

PMID29109762
PMCPMC5661601
OpenAlexW2754662247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.